Metraipolis › archive › dc_702ef9667e49
Clinical efficacy of Atezolizumab/Bevacizumab combined with TACE in treating BCLC stage C hepatocellular carcinoma — Europe PMC PMID:41939459
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41939459
- DOI
- 10.3389/fonc.2026.1744076
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-04T04:41:26.198Z
- SHA-256 of the archived text
64ba87478b4e975866eb987f5cdd43978e60dc545550570afd5e8f187d169f0f- Stable URL of this page
https://metraipolis.com/documento/dc_702ef9667e49
How to cite
Clinical efficacy of Atezolizumab/Bevacizumab combined with TACE in treating BCLC stage C hepatocellular carcinoma — Europe PMC PMID:41939459 — Europe PMC (en), https://europepmc.org/article/MED/41939459 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_702ef9667e49 (Metraipolis archive dc_702ef9667e49, sha256 64ba87478b4e975866eb987f5cdd43978e60dc545550570afd5e8f187d169f0f)
BibTeX
@misc{dc702ef9667e49,
title = {Clinical efficacy of Atezolizumab/Bevacizumab combined with TACE in treating BCLC stage C hepatocellular carcinoma — Europe PMC PMID:41939459},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41939459},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_702ef9667e49; sha256 64ba87478b4e975866eb987f5cdd43978e60dc545550570afd5e8f187d169f0f},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41939459. Agents can read the archived copy with the MCP tool read_document.